Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126282071 | 12628207 | 1 | I | 20160526 | 20160808 | 20160808 | PER | US-ASTRAZENECA-2016SE57687 | ASTRAZENECA | 0.00 | F | Y | 76.70000 | KG | 20160808 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126282071 | 12628207 | 1 | PS | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | 19810 | 20 | MG | CAPSULE | QD | |||||||
| 126282071 | 12628207 | 2 | SS | ELAVIL | AMITRIPTYLINE HYDROCHLORIDE | 1 | Oral | N | 0 | 100 | MG | TABLET | QD | ||||||
| 126282071 | 12628207 | 3 | SS | PROTONIX | PANTOPRAZOLE SODIUM | 1 | Intravenous (not otherwise specified) | 40.0MG UNKNOWN | U | 0 | 40 | MG | INJECTION | ||||||
| 126282071 | 12628207 | 4 | SS | CHANTIX | VARENICLINE TARTRATE | 1 | Unknown | U | 0 | 1 | MG | BID | |||||||
| 126282071 | 12628207 | 5 | C | ZYLOPRIM | ALLOPURINOL | 1 | Oral | 0 | 1 | DF | TABLET | QD | |||||||
| 126282071 | 12628207 | 6 | C | LIORESAL | BACLOFEN | 1 | Oral | 0 | 1 | DF | TABLET | BID | |||||||
| 126282071 | 12628207 | 7 | C | ESTRACE | ESTRADIOL | 1 | Oral | 0 | 1 | DF | QD | ||||||||
| 126282071 | 12628207 | 8 | C | LOFIBRA | FENOFIBRATE | 1 | Oral | 0 | 1 | DF | TABLET | QD | |||||||
| 126282071 | 12628207 | 9 | C | FLONASE | FLUTICASONE PROPIONATE | 1 | TWO SPRAY IN EACH NOSTRIL TWICE DAILY | 0 | |||||||||||
| 126282071 | 12628207 | 10 | C | NEURONTIN | GABAPENTIN | 1 | Oral | 0 | 1 | DF | CAPSULE | BID | |||||||
| 126282071 | 12628207 | 11 | C | NORCO | ACETAMINOPHENHYDROCODONE BITARTRATE | 1 | Oral | TAKE 1-2 TABLETS BY ,OUTH EVERY FOUR HOURS AS NEEDED | 0 | ||||||||||
| 126282071 | 12628207 | 12 | C | DUONEB | ALBUTEROL SULFATEIPRATROPIUM BROMIDE | 1 | USE ONE VIAL NEBULIZER FOUR TIES DAILY AS NEEDED | 0 | |||||||||||
| 126282071 | 12628207 | 13 | C | LORAZEPAM. | LORAZEPAM | 1 | 0 | ||||||||||||
| 126282071 | 12628207 | 14 | C | ATIVAN | LORAZEPAM | 1 | Oral | 0 | .5 | MG | TABLET | Q8H | |||||||
| 126282071 | 12628207 | 15 | C | ZOFRAN-ODT | 2 | Oral | 0 | 4 | MG | TABLET | Q8H | ||||||||
| 126282071 | 12628207 | 16 | C | PROVENTIL HFA | ALBUTEROL SULFATE | 1 | 6.7G UNKNOWN | 0 | 6.7 | G | |||||||||
| 126282071 | 12628207 | 17 | C | PROVENTIL HFA | ALBUTEROL SULFATE | 1 | 6.7G UNKNOWN | 0 | 6.7 | G | |||||||||
| 126282071 | 12628207 | 18 | C | DITROPAN-XL | 2 | Oral | 0 | 1 | DF | TABLET | QD | ||||||||
| 126282071 | 12628207 | 19 | C | INDERAL LA | PROPRANOLOL HYDROCHLORIDE | 1 | Oral | 0 | 1 | DF | CAPSULE | QD | |||||||
| 126282071 | 12628207 | 20 | C | ZANTAC | RANITIDINE HYDROCHLORIDE | 1 | Oral | 0 | 1 | DF | TABLET | QD | |||||||
| 126282071 | 12628207 | 21 | C | REQUIP | ROPINIROLE HYDROCHLORIDE | 1 | Oral | 0 | 1 | DF | TABLET | QD | |||||||
| 126282071 | 12628207 | 22 | C | MOBIC | MELOXICAM | 1 | Oral | 0 | 1 | DF | TABLET | QD | |||||||
| 126282071 | 12628207 | 23 | C | MORPHINE | MORPHINE | 1 | Intravenous (not otherwise specified) | 0 | |||||||||||
| 126282071 | 12628207 | 24 | C | SINGULAIR | MONTELUKAST SODIUM | 1 | Oral | 0 | 1 | DF | TABLET | QD | |||||||
| 126282071 | 12628207 | 25 | C | GI COCKTAIL | 2 | Oral | 0 | ||||||||||||
| 126282071 | 12628207 | 26 | C | NS | SODIUM CHLORIDE | 1 | Intravenous (not otherwise specified) | 0 | |||||||||||
| 126282071 | 12628207 | 27 | C | ZOFRAN | ONDANSETRON HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126282071 | 12628207 | 11 | Pain |
| 126282071 | 12628207 | 12 | Dyspnoea |
| 126282071 | 12628207 | 13 | Anxiety |
| 126282071 | 12628207 | 14 | Anxiety |
| 126282071 | 12628207 | 15 | Nausea |
| 126282071 | 12628207 | 16 | Dyspnoea |
| 126282071 | 12628207 | 17 | Wheezing |
| 126282071 | 12628207 | 22 | Chest pain |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126282071 | 12628207 | Chest pain | |
| 126282071 | 12628207 | Gastrooesophageal reflux disease | |
| 126282071 | 12628207 | Hypercholesterolaemia | |
| 126282071 | 12628207 | Skin lesion |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |